|
End-of-day quote
Nasdaq
2024-02-05
|
5-day change | 1st Jan Change | ||
| 0.3222 USD | -2.36% |
|
+2.32% | -20.05% |
| Market Cap | 226M 194M 183M 167M 312M 21.48B 313M 2.17B 838M 10.94B 848M 829M 34.66B | P/E 2026 * |
-1.34x | P/E 2027 * | -1.99x |
|---|---|---|---|---|---|
| Enterprise Value | 226M 194M 183M 167M 312M 21.48B 313M 2.17B 838M 10.94B 848M 829M 34.66B | EV / Sales 2026 * |
4.1x | EV / Sales 2027 * | 2.04x |
| Free-Float |
99.84% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript : Tonix Pharmaceuticals
| 1 day | -2.36% |
| Manager | Title | Age | Since |
|---|---|---|---|
Seth Lederman
CEO | Chief Executive Officer | 68 | 2007-11-15 |
Bradley Saenger
DFI | Director of Finance/CFO | 52 | 2016-01-31 |
Siobhan Fogarty
CTO | Chief Tech/Sci/R&D Officer | 57 | 2025-02-03 |
| Director | Title | Age | Since |
|---|---|---|---|
Seth Lederman
CHM | Chairman | 68 | 2011-09-30 |
Margaret Bell
BRD | Director/Board Member | 66 | 2017-09-11 |
Adeoye Olukotun
BRD | Director/Board Member | 81 | 2018-09-04 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.36% | +2.32% | - | - | 226M | |
| -0.11% | -3.00% | +49.92% | +88.95% | 1,002B | |
| -0.46% | -2.68% | +51.35% | +64.66% | 649B | |
| -0.04% | -4.81% | +18.40% | +67.16% | 440B | |
| -0.80% | -0.43% | +28.92% | +36.94% | 346B | |
| -0.13% | -14.97% | +9.41% | +26.44% | 263B | |
| -1.90% | -2.72% | -2.72% | +10.93% | 250B | |
| -0.69% | -11.67% | +39.72% | +49.47% | 213B | |
| -1.06% | -4.23% | -14.70% | -57.76% | 201B | |
| -0.61% | -2.41% | +26.12% | +89.51% | 182B | |
| Average | -0.80% | -2.06% | +22.94% | +41.81% | 393.74B | |
| Weighted average by Cap. | -0.44% | -2.39% | +32.01% | +55.93% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 55M 47.33M 44.57M 40.61M 75.98M 5.23B 76.28M 528M 204M 2.67B 207M 202M 8.45B | 111M 95.42M 89.85M 81.86M 153M 10.55B 154M 1.06B 412M 5.38B 416M 407M 17.03B |
| Net income | -169M -145M -137M -125M -233M -16.06B -234M -1.62B -626M -8.18B -634M -620M -25.91B | -164M -141M -133M -121M -227M -15.63B -228M -1.58B -610M -7.96B -617M -604M -25.23B |
| Net Debt | - | - |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- TNXP Stock
- TNXP Stock
Select your edition
All financial news and data tailored to specific country editions
